Neuland is named after Reverend Julius Aloysius (Athur) Nieuwland (1878-1936) an inspirational scientist at the University of Notre Dame, USA. He is known for his contributions to research into acetylene and its use as the basis for a type of synthetic rubber, which led to the invention of neoprene by DuPont.
His work inspired our chairman Dr Davuluri Rama Mohan Rao, who studied organic chemistry at the University of Notre Dame, to start his own business and name it after the Reverend Nieuwland.
1984-2003
Evolving for sustained growth
In 1986 we achieved our first API sale of salbutamol sulphate and albuterol sulphate. In its tenth year Neuland went public, and in 1997 we were successfully audited by the United States Food and Drug Administration (USFDA) for the first time.
2004-2013
Building our reputation
From 2004-2013 we strategically aligned our business towards niche APIs and custom manufacturing solutions. We began operating in the USA in 2004 and opened a subsidiary in Japan in 2007. Our dedicated research & development center opened in 2008 and our manufacturing facilities passed an EDQM audit in the same year, swiftly followed by PMDA Japan and our first new chemical entity (NCE) approval.
2014-2021
Building our portfolio
From 2014-2021 we branched into specialty API manufacturing. We organically grew our custom manufacturing solutions business by focusing on biotech companies. Our R&D facility was approved by the USFDA, and we focused on uninterrupted supply and quality.
2022-today
Accelerating growth
Since 2022 we have further strengthened our CMS capabilities and capacities, growing our reputation as a partner for biotech and pharmaceutical companies. We have built our GDS product pipeline with a focus on technology differentiation including peptides.
With Neuland, you always know that you will get quality products, delivered on time and on budget - that’s why they’ve been a trusted partner of ours for the past seven years.